A randomized, double-blind, placebo-controlled study of the use of viscous oral cromolyn sodium for the treatment of eosinophilic esophagitis.

CONCLUSION: Cromolyn, when mixed into a viscous preparation, did not significantly reduce esophageal eosinophilia. It did however reduce symptom scores (although not significantly more than placebo) and led to complete resolution in one subject. PMID: 29544738 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29544738?dopt=Abstract

Source: Annals of Allergy, Asthma and Immunology - March 12, 2018 Category: Allergy & Immunology Authors: Lieberman JA, Zhang J, Whitworth J, Cavender C Tags: Ann Allergy Asthma Immunol Source Type: research